Mountain West AETC

mountain west aetc
University of Washington

Harborview Medical Center
Mail Stop: 359932, 325 Ninth Avenue
Seattle, WA 98104
United States

Phone
(206) 543-2704
Email
[email protected]

Visit us Online

Regional Scope

The Mountain West AETC serves Alaska, Colorado, Idaho, Montana, Oregon, North and South Dakota, Utah, Washington, and Wyoming through its central office and local partners.

Contact

For HIV training, technical assistance, and/or capacity building assistance anywhere in the Mountain West  AETC region, contact [email protected].  

David Spach, MD
Principal Investigator
Laurie Sylla, MHSA
Program Director
Phone: (206) 221-4943
Clinton Amand, BSC, MA
Multimedia Specialist
Rolf Christensen, DDS, MHA
Dental Director
Paul F. Cook, PhD 
Program Evaluator
Carlos Flores, MSIM
Senior Computing Specialist
Marcee Kerr
Regional Program/QI Manager
Phone: (206) 221-4964
Meri Konishi
Fiscal Specialist
Pam Landinez
Telehealth Manager
Phone: (206) 685-9625
Susan Latta, BA
Program Support Specialist
Hillary Liss, MD 
Medical Program Director
Samantha Meiring, BA (Hon)
Practice Transformation Program Coordinator
Victor Ramirez, MSPH
Washington State Training Coordinator
Phone: (206) 543-3319
Lara Strick, MD, MSc
Corrections Program Director
Carrie Van Ness
Central and Eastern Washington Coordinator
Brian Wood, MD
MWAETC HIV ECHO Director/Trainer

Resources: 69

Title Publish Date Review Date
IAS 2022 Conference Highlights
Recent Trials of Second-Line ART: Lessons Learned & Applications to Clinical Practice
Health Inequities and HIV Vulnerability
Implementing Substance Use Disorder (SUD) Services in HIV Care Settings Toolkit
Cardiovascular Risks of Antiretroviral Therapy
Pneumocystis Pneumonia: Prevention & Treatment
Expedited Partner Therapy (EPT) Fact Sheet for Providers
ASCVD Risk Prediction to Guide Initial Statin Therapy for People with HIV
PrEP for PWID: Challenges and Opportunities
Fentanyl: A Hidden Epidemic
Pneumocystis Pneumonia: Part 1
CROI 2022 Highlights: HIV Co-infections
Expedited Partner Therapy in 2022: Updated Guidance and Practical Realities
Treatment for STIs: A Guide for Medical Providers
CROI 2022 Report Back: Treatment Updates
PrEP for HIV Prevention: The 4-1-1 on 2-1-1
Unhealthy Alcohol Use Among Persons with HIV: A Modifiable Barrier to Optimal Management of HIV and its Comorbidities
Challenging Structural Racism in Medicine: Intro to Key Concepts of Critical Race Theory
CROI 2022 Update: HIV Prevention
“Microdosing” Buprenorphine Inductions
PrEP for Prevention of HIV in the U.S., 2021 Update
ART Update: New Guidelines & Medications
Fentanyl and Other High Potency Synthetic Opioids
Revisiting the Invisible Latino HIV Crisis: Examining Progress and Identifying Remaining Gaps in the National Response
Dapivirine Ring for HIV PrEP
Microaggressions in Healthcare: How to Respond
Using HIV-ASSIST to Guide ART Decision-Making
2021 STI Treatment Guidelines Update
COVID-19 Vaccine: 3rd Doses & Boosters
Cryptococcosis in People with HIV: Updated Guidelines on Prevention & Treatment
Integrating Behavioral Health into Primary HIV Care — Covering the Bases
Fall Risk Evaluation & Management
2021 International AIDS Society Conference Highlights
“IM” Thinking About Using Long Acting Injectables
Treating Hepatitis C Among People who Use Drugs
Updates to the HHS Adult and Adolescent HIV Treatment Guidelines
Operationalizing Use of Long-Acting Injectable ART
Clinically Relevant Drug Interactions with Direct Acting Antivirals (DAAs)
Updates in TB Preventive Therapy Guidelines
Hepatitis C Treatment Update
Medications for Methamphetamine Use Disorder
Isolated Hepatitis B Core Antibody in People with HIV Infection
CROI 2021: Key Treatment Studies
What will PrEP Implementation Look Like Post-COVID?
CROI Update: HIV Co-Infections and Comorbidities
CROI 2021 Report Back
Prevention and Treatment of Hepatitis C Infection among People who Use Drugs
Microaggressions in Healthcare: Patient Experiences
Diabetes Medications for Type 2 Diabetes with Focus on HIV: Parts 1 & 2
Suicide and Overdose among People with HIV during the COVID-19 Pandemic: Updates and Opportunities for Mitigation
Pain Management in Individuals with Substance Use Disorders
Primary Care Considerations for Patients Using Methamphetamines
Telemedicine and Opioid Use Disorder (OUD) Part 2: Clinical Tips
Cabotegravir plus Rilpivirine (Cabenuva): Extended Release Injectable Suspension
Understanding Frailty
STIs and PrEP for People Who Inject Drugs
Risk, Presentation, Treatment, and Outcomes of COVID-19 in People with HIV
Hepatitis B Immunity in HIV: Case Vignette
Does this Patient Need PEP?
Telemedicine and Opioid Use Disorder: Regulatory Changes and Evidence
Results and Response to a 10-State COVID-19 Practice Impact Survey in the Mountain West Region
Telemedicine for People with HIV
HIV Non-Occupational Post-Exposure Prophylaxis (nPEP) and Processes of Patient Care
Implementing Telemedicine Webinar Series
Long-Acting Injectable Cabotegravir: the Future of HIV PrEP
Stigma and Addiction Training Slides
HIV Medication Chart Pad
HIV Medication Pocket Guide
Certification Resources for Health Care Professionals
Day Title
05/22 to 05/24 Mountain West Transforming Care Conference (Online, Utah)
Monday, May 22, 2023 (All day) to Wednesday, May 24, 2023 (All day)
Event type: Conferences & Events